Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis

Free Radical Biology and Medicine

Volumn 41, Issue 10, 2006, Pages 1566-1577

  Dai, Jing ^a,b   Li, Wenjing ^a,b   Chang, Lina ^a,b   Zhang, Zhenmin ^a,b   Tang, Chaoshu ^a,b   Wang, Nanping ^a,b   Zhu, Yi ^a,b   Wang, Xian ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Atherosclerosis; Homocysteine; MCP 1; Monocytes; Redox factor 1

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; REDOX EFFECTOR FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ISOLATION; CONTROLLED STUDY; DIET; DNA BINDING; ENZYME ACTIVITY; FEMALE; FOAM CELL; GENE ACTIVITY; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR MECHANICS; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINE CCL2; DIET; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; FOAM CELLS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MACROPHAGES, PERITONEAL; MICE; MICE, MUTANT STRAINS; MONOCYTES; NADP; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 33749521052     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.08.020     Document Type: Article

References (44)

1. McCully K.S. Homocysteine and vascular disease. Nat. Med. 2 (1996) 386-389
2. Guthikonda S., and Haynes W.G. Homocysteine as a novel risk factor for atherosclerosis. Curr. Opin. Cardiol. 14 (1999) 283-291
3. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran Jr. L.J., Kohl B., Rao V., Kisiel W., Stern D.M., and Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107 (2001) 675-683
4. Zhou J., Moller J., Danielsen C.C., Bentzon J., Ravn H.B., Austin R.C., and Falk E. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1470-1476
5. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
6. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
7. Valente A.J., Rozek M.M., Sprague E.A., and Schwartz C.J. Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1. Circulation 86 (1992) III20-III25
8. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., and Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2 (1998) 275-281
9. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
10. Zeng X., Dai J., Remick D.G., and Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ. Res. 93 (2003) 311-320
11. Wang G., Woo C.W., Sung F.L., and Siow Y.L.O.K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1777-1783
12. Au-Yeung K.K., Woo C.W., Sung F.L., Yip J.C., and Siow Y.L.O.K. Hyperhomocysteinemia activates nuclear factor-kappa B in endothelial cells via oxidative stress. Circ. Res. 94 (2004) 28-36
13. Xanthoudakis S., Miao G., Wang F., Pan Y.C., and Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11 (1992) 3323-3335
14. Nishi T., Shimizu N., Hiramoto M., Sato I., Yamaguchi Y., Hasegawa M., Aizawa S., Tanaka H., Kataoka K., Watanabe H., and Handa H. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J. Biol. Chem. 277 (2002) 44548-44556
15. Zhou J., Werstuck G.H., Lhotak S., de Koning A.B., Sood S.K., Hossain G.S., Moller J., Ritskes-Hoitinga M., Falk E., Dayal S., Lentz S.R., and Austin R.C. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 110 (2004) 207-213
16. Li W., Hou L., Hua Z., and Wang X. Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. FASEB J. 18 (2004) 1603-1605
17. Wang G., Dai J., Mao J., Zeng X., Yang X., and Wang X. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis 179 (2005) 395-402
18. Mitomo K., Nakayama K., Fujimoto K., Sun X., Seki S., and Yamamoto K. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145 (1994) 197-203
19. Wang H., Jiang X., Yang F., Gaubatz J.W., Ma L., Magera M.J., Yang X., Berger P.B., Durante W., Pownall H.J., and Schafer A.I. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 101 (2003) 3901-3907
20. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., and Selhub J. The atherogenic effect of excess methionine intake. Proc. Natl. Acad. Sci. USA 100 (2003) 15089-15094
21. Eikelboom J.W., Lonn E., Genest Jr. J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131 (1999) 363-375
22. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., Heydrick S., Stark R., Klings E.S., Moldovan N.I., Yaghoubi M., Goldschmidt-Clermont P.J., Farber H.W., Cohen R., and Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 106 (2000) 483-491
23. Sutton-Tyrrell K., Bostom A., Selhub J., and Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 96 (1997) 1745-1749
24. Lentz S.R., Sobey C.G., Piegors D.J., Bhopatkar M.Y., Faraci F.M., Malinow M.R., and Heistad D.D. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J. Clin. Invest. 98 (1996) 24-29
25. Azumi H., Inoue N., Ohashi Y., Terashima M., Mori T., Fujita H., Awano K., Kobayashi K., Maeda K., Hata K., Shinke T., Kobayashi S., Hirata K., Kawashima S., Itabe H., Hayashi Y., Imajoh-Ohmi S., Itoh H., and Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1838-1844
26. Leusen J.H., Verhoeven A.J., and Roos D. Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family. Front. Biosci. 1 (1996) d72-d90
27. Ungvari Z., Csiszar A., Edwards J.G., Kaminski P.M., Wolin M.S., Kaley G., and Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 418-424
28. phox subunit of NADPH oxidase. Circulation 111 (2005) 2112-2118
29. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11 (1994) 95-102
30. Guan Z., Basi D., Li Q., Mariash A., Xia Y.F., Geng J.G., Kao E., and Hall J.L. Loss of redox factor 1 decreases NF-kappa B activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 96-101
31. Hall J.L., Wang X., Van A., Zhao Y., and Gibbons G.H. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappa B-independent and-dependent pathways. Circ. Res. 88 (2001) 1247-1253
32. Yoo Y.H., Lim Y.J., Park S.E., Kim J.M., and Park Y.C. Overexpression of redox factor-1 negatively regulates NO synthesis and apoptosis in LPS-stimulated RAW 264.7 macrophages. FEBS Lett. 556 (2004) 39-42
33. 2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127 (2004) 845-858
34. Flaherty D.M., Monick M.M., Carter A.B., Peterson M.W., and Hunninghake G.W. Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages. J. Immunol. 168 (2002) 5675-5681
35. Ozaki M., Suzuki S., and Irani K. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J. 16 (2002) 889-890
36. Angkeow P., Deshpande S.S., Qi B., Liu Y.X., Park Y.C., Jeon B.H., Ozaki M., and Irani K. Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis. Cell. Death Differ. 9 (2002) 717-725
37. Kakolyris S., Kaklamanis L., Giatromanolaki A., Koukourakis M., Hickson I.D., Barzilay G., Turley H., Leek R.D., Kanavaros P., Georgoulias V., Gatter K.C., and Harris A.L. Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease. Histopathology 33 (1998) 561-569
38. Monick M.M., Carter A.B., and Hunninghake G.W. Human alveolar macrophages are markedly deficient in REF-1 and AP-1 DNA binding activity. J. Biol. Chem. 274 (1999) 18075-18080
39. Liu X.M., Peyton K.J., Ensenat D., Wang H., Schafer A.I., Alam J., and Durante W. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle. Role in cell survival. J. Biol. Chem. 280 (2005) 872-877
40. Upchurch Jr. G.R., Welch G.N., Fabian A.J., Freedman J.E., Johnson J.L., Keaney Jr. J.F., and Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272 (1997) 17012-17017
41. Nishio E., and Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br. J. Pharmacol. 122 (1997) 269-274
42. Wilcken D.E., Wang X.L., Adachi T., Hara H., Duarte N., Green K., and Wilcken B. Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1199-1202
43. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., and Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932
44. Herring C.J., Deans B., Elder R.H., Rafferty J.A., MacKinnon J., Barzilay G., Hickson I.D., Hendry J.H., and Margison G.P. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. Br. J. Cancer 80 (1999) 940-945